Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California. The company was founded in 2002 and is based in Valbonne, France.

EURONEXT:ALMDT

Median Technologies SA

Last Close

6.82

30/08 15:39

Market Cap

46.65M

Beta: 1.88

Volume Today

738.48K

Avg: 36.60K

PE Ratio

−3.00

PFCF: −4.10

Filings Not Available